0000950170-24-071919.txt : 20240611
0000950170-24-071919.hdr.sgml : 20240611
20240611161809
ACCESSION NUMBER: 0000950170-24-071919
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hughes-Wilson Alexandra
CENTRAL INDEX KEY: 0002005875
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38452
FILM NUMBER: 241036006
MAIL ADDRESS:
STREET 1: C/O MEREO BIOPHARMA
STREET 2: 1 CAVENDISH PLACE
CITY: LONDON
STATE: X0
ZIP: W1G 0QF
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mereo BioPharma Group plc
CENTRAL INDEX KEY: 0001719714
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
BUSINESS PHONE: 4403330237300
MAIL ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Mereo Biopharma Group plc
DATE OF NAME CHANGE: 20171016
4/A
1
ownership.xml
4/A
X0508
4/A
2024-05-22
2024-05-23
0001719714
Mereo BioPharma Group plc
MREO
0002005875
Hughes-Wilson Alexandra
C/O MEREO BIOPHARMA GROUP PLC
4TH FLOOR, ONE CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
false
true
false
false
See Remarks
false
American Depositary Shares representing Ordinary Shares
7650
D
Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
This Amended Form 4 amends the Form 4 filed by the Reporting Person on May 23, 2024 (the "Original Form 4"). The transactions reported in the Original Form 4 were canceled in their entirety prior to settlement and, as a result, no shares were transferred.
Chief Patient Access and Commercial Planning
/s/ Christine Fox, by power of attorney
2024-06-11